Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study

被引：0
|
作者：
Naohisa Uchimura
Atsushi Kamijo
Takao Takase
机构：
[1] Kurume University School of Medicine,Department of Neuropsychiatry
[2] Eisai Co.,undefined
[3] Ltd.,undefined
来源：
Annals of General Psychiatry | / 11卷
关键词：
Elderly; Long-term; Eszopiclone; Insomnia; Psychiatric disorder; Quality of life; Japanese;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study
    Uchimura, Naohisa
    Kamijo, Atsushi
    Takase, Takao
    [J]. ANNALS OF GENERAL PSYCHIATRY, 2012, 11
  • [2] A 24-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of the Rivastigmine Patch in Japanese Patients with Alzheimer's Disease
    Nakamura, Yu
    Imai, Yukimichi
    Shigeta, Masahiro
    Graf, Ana
    Shirahase, Toru
    Kim, Hyosung
    Fujii, Akifumi
    Mori, Joji
    Homma, Akira
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 163 - 179
  • [3] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Kohji Shirai
    Toru Fujita
    Michitaka Tanaka
    Yuka Fujii
    Masatsugu Shimomasuda
    Soichi Sakai
    Yoshishige Samukawa
    [J]. Advances in Therapy, 2019, 36 : 86 - 100
  • [4] Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study
    Uchimura, Naohisa
    Ogawa, Atsushi
    Hamamura, Misako
    Hashimoto, Takamasa
    Nagata, Hiroshi
    Uchiyama, Makoto
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (02) : 215 - 224
  • [5] Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study
    Shirai, Kohji
    Fujita, Toru
    Tanaka, Michitaka
    Fujii, Yuka
    Shimomasuda, Masatsugu
    Sakai, Soichi
    Samukawa, Yoshishige
    [J]. ADVANCES IN THERAPY, 2019, 36 (01) : 86 - 100
  • [6] Efficacy and safety of muraglitazar: a double-blind, 24-week, dose-ranging study in patients with type 2 diabetes
    Rubin, Cindy J.
    Viraswami-Appanna, Kalyanee
    Fiedorek, Fred T.
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2009, 6 (03): : 205 - 215
  • [7] A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care
    Wade, A
    Crawford, GM
    Angus, M
    Wilson, R
    Hamilton, L
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (03) : 133 - 141
  • [8] Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study
    Simpson, Richard W.
    Nicholson, Geoffrey C.
    Proietto, Joseph
    Sarah, Alana
    Sanders, Kerrie M.
    Phillips, Gabrielle
    Chambers, Jo
    MacGinley, Rob
    Orford, Neil
    Walder, Ken
    Krippner, Guy
    Skoff, Kathy
    Wacher, Vincent J.
    [J]. DIABETES CARE, 2014, 37 (11) : 3121 - 3123
  • [9] Safety and efficacy of paliperidone extendedrelease in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
    Zhang, Hongyan
    Li, Huafang
    Liu, Yanning
    Wu, Cathy
    Wu, Qingqi
    Nuamah, Isaac
    Shi, Jianguo
    Xie, Shiping
    Wang, Gang
    Gopal, Srihari
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 69 - 77
  • [10] Efficacy and safety of canagliflozin rnonotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study
    Inagaki, Nobuya
    Kondo, Kazuoki
    Yoshinari, Toru
    Takahashi, Nahoko
    Susuta, Yutaka
    Kuki, Hideki
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (11) : 1501 - 1515
12345